Dr. Jeffrey Sparling is an interventional cardiologist with INTEGRIS Cardiovascular Physicians at INTEGRIS Heart Hospital.
Dr. Sparling completed medical school at the University of Oklahoma College of Medicine, where he completed a residency in Internal Medicine and served as chief medical resident. He started his fellowship in Cardiovascular Diseases at OU, and continued his fellowship training at Harvard Medical School's Brigham and Women's Hospital, studying structural heart and peripheral vascular interventions. While there, he was fortunate to be an active participant in the initial clinical trials involving catheter-based treatment for valvular heart disease.
He is ABIM Board Certified in cardiovascular disease and interventional cardiology with advanced training in the care of structural heart and peripheral vascular disease. Dr. Sparling's areas of interest are in percutaneous coronary intervention, peripheral arterial disease, carotid artery disease, repair of structural heart defects and catheter-based cardiac valve interventions. He currently serves as a clinical associate professor in the University of Oklahoma Department of Internal Medicine, and is on the Board of Directors for the clinical faculty at OU. He in on the Board of Directors for the Central Oklahoma chapter for the American Heart Association, and served as its president from 2014-2016. He is the director of cardiovascular services for the Oklahoma City Thunder, a role he has served in since 2011. He is a primary investigator or sub-investigator for multiple clinical trials at INTEGRIS Heart Hospital, including those for aortic valve disease, coronary artery disease, and pharmacologic therapies for heart disease. He is an Oklahoma City native and his interests outside of practicing medicine include cheering for the Oklahoma City Thunder with his family and spending time boating on Lake Tenkiller.
In addition to his office at INTEGRIS Baptist Medical Center, Dr. Sparling also sees patients in